New insights into molecular mechanisms of diabetic kidney disease.
about
Management of anemia in patients with diabetic kidney disease: A consensus statementGenetics of cardiovascular and renal complications in diabetesThe effects of glucose-lowering therapies on diabetic kidney diseaseRotenone remarkably attenuates oxidative stress, inflammation, and fibrosis in chronic obstructive uropathyGenetic modulation of diabetic nephropathy among mouse strains with Ins2 Akita mutation.The PPARγ2 Pro12Ala variant is protective against progression of nephropathy in people with type 2 diabetes.Semaphorin3a promotes advanced diabetic nephropathyMicroRNA-687 Induced by Hypoxia-Inducible Factor-1 Targets Phosphatase and Tensin Homolog in Renal Ischemia-Reperfusion Injury.Increased urinary Smad3 is significantly correlated with glomerular hyperfiltration and a reduced glomerular filtration rate and is a new urinary biomarker for diabetic nephropathy.miR-93 regulates Msk2-mediated chromatin remodelling in diabetic nephropathyEffect of breviscapine injection on clinical parameters in diabetic nephropathy: A meta-analysis of randomized controlled trials.Inhibition of the processing of miR-25 by HIPK2-Phosphorylated-MeCP2 induces NOX4 in early diabetic nephropathy.The Leaf of Diospyros kaki Thumb Ameliorates Renal Oxidative Damage in Mice with Type 2 Diabetes.Use and isolation of urinary exosomes as biomarkers for diabetic nephropathy.Association between the RAGE gene -374T/A, -429T/C polymorphisms and diabetic nephropathy: a meta-analysis.Spironolactone promotes autophagy via inhibiting PI3K/AKT/mTOR signalling pathway and reduce adhesive capacity damage in podocytes under mechanical stress.High glucose induces renal tubular epithelial injury via Sirt1/NF-kappaB/microR-29/Keap1 signal pathway.Deletion of the gene for adiponectin accelerates diabetic nephropathy in the Ins2 (+/C96Y) mouse.Association of kidney structure-related gene variants with type 2 diabetes-attributed end-stage kidney disease in African Americans.Protective effect of berberine on renal fibrosis caused by diabetic nephropathy.A breath of fresh air for diabetic nephropathy.Increased Oxidative Damage of RNA in Early-Stage Nephropathy in db/db Mice.The role of oxidative stress in streptozotocin-induced diabetic nephropathy in rats.MDM2 is implicated in high-glucose-induced podocyte mitotic catastrophe via Notch1 signalling.Mitochondria Damage and Kidney Disease.Protective effect of vascular endothelial growth factor against cardiopulmonary bypass-associated acute kidney injury in beagles.Influence of Dipeptidyl Peptidase-IV Inhibitor Sitagliptin on Extracellular Signal-Regulated Kinases 1/2 Signaling in Rats with Diabetic Nephropathy.Changes in the inflammatory markers with advancing stages of diabetic nephropathy and the role of pentraxin-3.Acute Kidney Injury and Progression of Diabetic Kidney Disease.FGF23C-tail improves diabetic nephropathy by attenuating renal fibrosis and inflammation.Renal Outcomes of Antidiabetic Treatment Options for Type 2 Diabetes-A Proposed MARE Definition
P2860
Q26752692-CF55749F-E540-45FE-B635-A3396F092C29Q26752749-3F064819-A564-41F4-B1E2-850EB3F04BE0Q33583220-11264147-086A-4901-AFF1-667C38A93B23Q34033183-6F127C58-1E02-4437-A2AF-35AC32A07590Q34631925-211BE9F1-23D8-4BC2-8AC6-A0C4146BDCE6Q35174597-9B3B2E5B-3137-4438-98B6-C39D6996FBA1Q35532272-549DB873-E71C-4FCB-B249-D2F990755217Q35790556-ADD1E440-670C-42A2-B4EC-26BA54FF4F5AQ36142232-9D920CAD-A41D-4A45-8F4D-8AD5B20BBC45Q37061198-8F5B241D-2B20-4892-9A71-3DB2DB998070Q37204321-0D008915-719D-4E05-9207-E10943BBE585Q37493523-981BE083-E3C8-4F63-8724-22846346DACFQ37564931-CF2889CE-8F7C-45E9-91E7-049BF133B9C2Q38259561-7BD0A43D-1049-4EA8-AE73-FF2540DE3AB5Q38364408-F80BEC8C-4B47-4DF0-A7AC-DDB9121E1AA1Q39809455-A6A9A396-25FC-467F-8AB9-B4CB8A3C0656Q40340196-F745338B-6468-4D57-AE89-7055D84BB9EAQ40958038-06BE742E-1849-4735-B2E4-AC44F3B194AAQ42672940-C7CF036A-CCA9-41AC-9EB2-141B0CCA64D8Q42835125-AF3B6102-78AF-4A6D-A000-C1FEA9C4D5C8Q43123393-8336AC2E-79D6-4860-B285-7012A2619397Q45716309-0F23FF5C-8B93-4279-BA8F-801356B7E604Q46463694-01066BFE-DB2D-4B2D-B8F7-A978EAD025A3Q47117632-A4C49DEA-E021-4667-AE36-EBA0AD6729D0Q48026176-A4C0651C-43AF-4F15-84C6-CFD4407DFDD9Q49335515-44320A55-42F0-408B-B06D-8AA6EC2B9818Q50782080-253C7A42-36D1-463A-BFF8-1BDC484A08DAQ51629721-CF000C2E-D1A4-4643-BEA7-C5EC03F6331EQ52724019-5AAFCB03-23D2-421B-8655-7EBF704D3E8AQ55409905-981427BD-C6D0-4393-A8D2-BAA4289D47FEQ57179232-26DCD36F-F7CB-410D-8802-0B569AB9E71D
P2860
New insights into molecular mechanisms of diabetic kidney disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New insights into molecular mechanisms of diabetic kidney disease.
@en
New insights into molecular mechanisms of diabetic kidney disease.
@nl
type
label
New insights into molecular mechanisms of diabetic kidney disease.
@en
New insights into molecular mechanisms of diabetic kidney disease.
@nl
prefLabel
New insights into molecular mechanisms of diabetic kidney disease.
@en
New insights into molecular mechanisms of diabetic kidney disease.
@nl
P2860
P1476
New insights into molecular mechanisms of diabetic kidney disease.
@en
P2093
Farhad R Danesh
Shawn S Badal
P2860
P304
P356
10.1053/J.AJKD.2013.10.047
P433
P577
2014-02-01T00:00:00Z